RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease.
Marta B AfonsoTawhidul IslamJulie MagustoRicardo AmorimVéronique LenoirRui F SimõesJosé TeixeiraLiana C SilvaDominique WendumIsabelle JéruCorinne VigourouxRui E CastroPaulo J OliveiraCarina Prip-BuusVlad RatziuJérémie GautheronCecília Maria Pereira RodriguesPublished in: Hepatology (Baltimore, Md.) (2022)
Ripk3 deficiency restores mitochondria bioenergetics and impacts LD dynamics. RIPK3 inhibition is promising in ameliorating NAFLD.